228 related articles for article (PubMed ID: 34800659)
1. Design of a population-based longitudinal cohort study of SARS-CoV-2 incidence and prevalence among adults in the San Francisco Bay Area.
Lindan CP; Desai M; Boothroyd D; Judson T; Bollyky J; Sample H; Weng Y; Cheng Y; Dahlen A; Hedlin H; Grumbach K; Henne J; Garcia S; Gonzales R; Craik CS; Rutherford G; Maldonado Y
Ann Epidemiol; 2022 Mar; 67():81-100. PubMed ID: 34800659
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
[TBL] [Abstract][Full Text] [Related]
3. Association of protective behaviors with SARS-CoV-2 infection: results from a longitudinal cohort study of adults in the San Francisco Bay Area.
Judson TJ; Zhang S; Lindan CP; Boothroyd D; Grumbach K; Bollyky JB; Sample HA; Huang B; Desai M; Gonzales R; Maldonado Y; Rutherford G;
Ann Epidemiol; 2023 Oct; 86():1-7. PubMed ID: 37524216
[TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 seroprevalence, and IgG concentration and pseudovirus neutralising antibody titres after infection, compared by HIV status: a matched case-control observational study.
Spinelli MA; Lynch KL; Yun C; Glidden DV; Peluso MJ; Henrich TJ; Gandhi M; Brown LB
Lancet HIV; 2021 Jun; 8(6):e334-e341. PubMed ID: 33933189
[TBL] [Abstract][Full Text] [Related]
5. Community Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 Disproportionately Affects the Latinx Population During Shelter-in-Place in San Francisco.
Chamie G; Marquez C; Crawford E; Peng J; Petersen M; Schwab D; Schwab J; Martinez J; Jones D; Black D; Gandhi M; Kerkhoff AD; Jain V; Sergi F; Jacobo J; Rojas S; Tulier-Laiwa V; Gallardo-Brown T; Appa A; Chiu C; Rodgers M; Hackett J; ; Kistler A; Hao S; Kamm J; Dynerman D; Batson J; Greenhouse B; DeRisi J; Havlir DV
Clin Infect Dis; 2021 Jul; 73(Suppl 2):S127-S135. PubMed ID: 32821935
[TBL] [Abstract][Full Text] [Related]
6. Predominance of antibody-resistant SARS-CoV-2 variants in vaccine breakthrough cases from the San Francisco Bay Area, California.
Servellita V; Morris MK; Sotomayor-Gonzalez A; Gliwa AS; Torres E; Brazer N; Zhou A; Hernandez KT; Sankaran M; Wang B; Wong D; Wang C; Zhang Y; Reyes KR; Glasner D; Deng X; Streithorst J; Miller S; Frias E; Rodgers M; Cloherty G; Hackett J; Hanson C; Wadford D; Philip S; Topper S; Sachdev D; Chiu CY
Nat Microbiol; 2022 Feb; 7(2):277-288. PubMed ID: 35013591
[TBL] [Abstract][Full Text] [Related]
7. Assessment of SARS-CoV-2 Seropositivity During the First and Second Viral Waves in 2020 and 2021 Among Canadian Adults.
Tang X; Sharma A; Pasic M; Brown P; Colwill K; Gelband H; Birnboim HC; Nagelkerke N; Bogoch II; Bansal A; Newcombe L; Slater J; Rodriguez PS; Huang G; Fu SH; Meh C; Wu DC; Kaul R; Langlois MA; Morawski E; Hollander A; Eliopoulos D; Aloi B; Lam T; Abe KT; Rathod B; Fazel-Zarandi M; Wang J; Iskilova M; Pasculescu A; Caldwell L; Barrios-Rodiles M; Mohammed-Ali Z; Vas N; Santhanam DR; Cho ER; Qu K; Jha S; Jha V; Suraweera W; Malhotra V; Mastali K; Wen R; Sinha S; Reid A; Gingras AC; Chakraborty P; Slutsky AS; Jha P;
JAMA Netw Open; 2022 Feb; 5(2):e2146798. PubMed ID: 35171263
[TBL] [Abstract][Full Text] [Related]
8. Severe Acute Respiratory Syndrome Coronavirus 2 Cumulative Incidence, United States, August 2020-December 2020.
Sullivan PS; Siegler AJ; Shioda K; Hall EW; Bradley H; Sanchez T; Luisi N; Valentine-Graves M; Nelson KN; Fahimi M; Kamali A; Sailey C; Lopman BA
Clin Infect Dis; 2022 Apr; 74(7):1141-1150. PubMed ID: 34245245
[TBL] [Abstract][Full Text] [Related]
9. Estimated Community Seroprevalence of SARS-CoV-2 Antibodies - Two Georgia Counties, April 28-May 3, 2020.
Biggs HM; Harris JB; Breakwell L; Dahlgren FS; Abedi GR; Szablewski CM; Drobeniuc J; Bustamante ND; Almendares O; Schnall AH; Gilani Z; Smith T; Gieraltowski L; Johnson JA; Bajema KL; McDavid K; Schafer IJ; Sullivan V; Punkova L; Tejada-Strop A; Amiling R; Mattison CP; Cortese MM; Ford SE; Paxton LA; Drenzek C; Tate JE;
MMWR Morb Mortal Wkly Rep; 2020 Jul; 69(29):965-970. PubMed ID: 32701941
[TBL] [Abstract][Full Text] [Related]
10. Development and Implementation of Dried Blood Spot-Based COVID-19 Serological Assays for Epidemiologic Studies.
Wong MP; Meas MA; Adams C; Hernandez S; Green V; Montoya M; Hirsch BM; Horton M; Quach HL; Quach DL; Shao X; Fedrigo I; Zermeno A; Huffaker J; Montes R; Madden A; Cyrus S; McDowell D; Williamson P; Contestable P; Stone M; Coloma J; Busch MP; Barcellos LF; Harris E
Microbiol Spectr; 2022 Jun; 10(3):e0247121. PubMed ID: 35612315
[TBL] [Abstract][Full Text] [Related]
11. A Multiplex Noninvasive Salivary Antibody Assay for SARS-CoV-2 Infection and Its Application in a Population-Based Survey by Mail.
Egorov AI; Griffin SM; Fuzawa M; Kobylanski J; Grindstaff R; Padgett W; Simmons S; Hallinger DR; Styles JN; Wickersham L; Sams E; Hudgens E; Wade TJ
Microbiol Spectr; 2021 Oct; 9(2):e0069321. PubMed ID: 34523986
[TBL] [Abstract][Full Text] [Related]
12. Estimated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Based on Blood Donations, July 2020-May 2021.
Jones JM; Stone M; Sulaeman H; Fink RV; Dave H; Levy ME; Di Germanio C; Green V; Notari E; Saa P; Biggerstaff BJ; Strauss D; Kessler D; Vassallo R; Reik R; Rossmann S; Destree M; Nguyen KA; Sayers M; Lough C; Bougie DW; Ritter M; Latoni G; Weales B; Sime S; Gorlin J; Brown NE; Gould CV; Berney K; Benoit TJ; Miller MJ; Freeman D; Kartik D; Fry AM; Azziz-Baumgartner E; Hall AJ; MacNeil A; Gundlapalli AV; Basavaraju SV; Gerber SI; Patton ME; Custer B; Williamson P; Simmons G; Thornburg NJ; Kleinman S; Stramer SL; Opsomer J; Busch MP
JAMA; 2021 Oct; 326(14):1400-1409. PubMed ID: 34473201
[TBL] [Abstract][Full Text] [Related]
13. Seroprevalence and humoral immune durability of anti-SARS-CoV-2 antibodies in Wuhan, China: a longitudinal, population-level, cross-sectional study.
He Z; Ren L; Yang J; Guo L; Feng L; Ma C; Wang X; Leng Z; Tong X; Zhou W; Wang G; Zhang T; Guo Y; Wu C; Wang Q; Liu M; Wang C; Jia M; Hu X; Wang Y; Zhang X; Hu R; Zhong J; Yang J; Dai J; Chen L; Zhou X; Wang J; Yang W; Wang C
Lancet; 2021 Mar; 397(10279):1075-1084. PubMed ID: 33743869
[TBL] [Abstract][Full Text] [Related]
14. Seroprevalence of Antibodies to SARS-CoV-2 in 10 Sites in the United States, March 23-May 12, 2020.
Havers FP; Reed C; Lim T; Montgomery JM; Klena JD; Hall AJ; Fry AM; Cannon DL; Chiang CF; Gibbons A; Krapiunaya I; Morales-Betoulle M; Roguski K; Rasheed MAU; Freeman B; Lester S; Mills L; Carroll DS; Owen SM; Johnson JA; Semenova V; Blackmore C; Blog D; Chai SJ; Dunn A; Hand J; Jain S; Lindquist S; Lynfield R; Pritchard S; Sokol T; Sosa L; Turabelidze G; Watkins SM; Wiesman J; Williams RW; Yendell S; Schiffer J; Thornburg NJ
JAMA Intern Med; 2020 Jul; ():. PubMed ID: 32692365
[TBL] [Abstract][Full Text] [Related]
15. Cohort profile: evaluation of immune response and household transmission of SARS-CoV-2 in Costa Rica: the RESPIRA study.
Loria V; Aparicio A; Hildesheim A; Cortés B; Barrientos G; Retana D; Sun K; Ocampo R; Prevots DR; Zúñiga M; Waterboer T; Wong-McClure R; Morera M; Butt J; Binder M; Abdelnour A; Calderón A; Gail MH; Pfeiffer RM; Solís CB; Fantin R; Vanegas JC; Mercado R; Ávila C; Porras C; Herrero R
BMJ Open; 2023 Dec; 13(12):e071284. PubMed ID: 38070892
[TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2 infection in central North Carolina: Protocol for a population-based longitudinal cohort study and preliminary participant results.
Miller EM; Law EA; Ajeen R; Karasik J; Mendoza C; Abernathy H; Garrett H; King E; Wallace J; Zelek M; Edwards JK; Xiong K; Beatty C; Fleischauer AT; Ciccone EJ; Shook-Sa BE; Aiello AE; Boyce RM
PLoS One; 2021; 16(10):e0259070. PubMed ID: 34695156
[TBL] [Abstract][Full Text] [Related]
17. Early Adoption of Longitudinal Surveillance for SARS-CoV-2 among Staff in Long-Term Care Facilities: Prevalence, Virologic and Sequence Analysis.
Gallichotte EN; Quicke KM; Sexton NR; Fitzmeyer E; Young MC; Janich AJ; Dobos K; Pabilonia KL; Gahm G; Carlton EJ; Ebel GD; Ehrhart N
Microbiol Spectr; 2021 Dec; 9(3):e0100321. PubMed ID: 34756092
[TBL] [Abstract][Full Text] [Related]
18. Mild SARS-CoV-2 Illness Is Not Associated with Reinfections and Provides Persistent Spike, Nucleocapsid, and Virus-Neutralizing Antibodies.
Schuler CF; Gherasim C; O'Shea K; Manthei DM; Chen J; Zettel C; Troost JP; Kennedy AA; Tai AW; Giacherio DA; Valdez R; Baldwin JL; Baker JR
Microbiol Spectr; 2021 Oct; 9(2):e0008721. PubMed ID: 34468184
[TBL] [Abstract][Full Text] [Related]
19. Anti-SARS-CoV-2 seroprevalence in King County, WA-Cross-sectional survey, August 2020.
Cowgill KD; Erosheva EA; Elder A; Miljacic L; Buskin S; Duchin JS
PLoS One; 2022; 17(8):e0272783. PubMed ID: 35994500
[TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2 seropositivity and subsequent infection risk in healthy young adults: a prospective cohort study.
Letizia AG; Ge Y; Vangeti S; Goforth C; Weir DL; Kuzmina NA; Balinsky CA; Chen HW; Ewing D; Soares-Schanoski A; George MC; Graham WD; Jones F; Bharaj P; Lizewski RA; Lizewski SE; Marayag J; Marjanovic N; Miller CM; Mofsowitz S; Nair VD; Nunez E; Parent DM; Porter CK; Santa Ana E; Schilling M; Stadlbauer D; Sugiharto VA; Termini M; Sun P; Tracy RP; Krammer F; Bukreyev A; Ramos I; Sealfon SC
Lancet Respir Med; 2021 Jul; 9(7):712-720. PubMed ID: 33865504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
